NCT05506423
Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Active, Not Recruiting
Not specifiedAges 21+ObservationalIantrek, Inc.
~300 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:CycloPen Cyclodialysis System
At a glance
Recruiting sites
0 of 16 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent of eyes with intraocular pressure (IOP) reduction ≥ 20% in comparison with baseline
Measured over 12 months postoperative
Conditions
Where it's being run
16 sites across 12 statesFlorida3
Maryland2
New York2
California1
Georgia1
Nevada1
New Jersey1
Pennsylvania1
Study leadership
- Tsontcho Ianchulev, MD,MPH · STUDY_CHAIR · Iantrek, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Percent of eyes with intraocular pressure (IOP) reduction ≥ 20% in comparison with baseline12 months postoperative
Intraocular pressure (IOP) is at least 20% lower than before surgery without additional ocular hypotensive medications or IOP-lowering surgery